Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 546-46-3
2. Trizinc Dicitrate
3. Citric Acid, Zinc Salt
4. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Zinc Salt (2:3)
5. K72i3dex9b
6. Trizinc;2-hydroxypropane-1,2,3-tricarboxylate
7. 2-hydroxy-1,2,3-propanetricarboxylic Acid Zinc Salt
8. 5590-32-9
9. Einecs 208-901-2
10. Unii-k72i3dex9b
11. Zinccitrate
12. Kopcitrate-zn
13. Trizinc 2-hydroxypropane-1,2,3-tricarboxylate
14. Citrated Zinc
15. Citric Acid, Zinc Salt (2:3)
16. Zinc Citrate [mi]
17. Ec 208-901-2
18. Zinc Citrate [inci]
19. Citrated Zinc [vandf]
20. Zinc Citrate [mart.]
21. Zinc Citrate [who-dd]
22. 2-hydroxy-1,2,3-propanetricarboxylic Acid, Zinc Salt
23. Dtxsid90889427
24. Mfcd00054367
25. Akos015918265
26. Db11154
27. Ft-0658839
28. Trizinc 2-oxidanylpropane-1,2,3-tricarboxylate
29. A830284
30. Q27282034
Molecular Weight | 574.3 g/mol |
---|---|
Molecular Formula | C12H10O14Zn3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 4 |
Exact Mass | 571.79137 g/mol |
Monoisotopic Mass | 569.79448 g/mol |
Topological Polar Surface Area | 281 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 211 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
53
PharmaCompass offers a list of Zinc Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zinc Citrate manufacturer or Zinc Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zinc Citrate manufacturer or Zinc Citrate supplier.
PharmaCompass also assists you with knowing the Zinc Citrate API Price utilized in the formulation of products. Zinc Citrate API Price is not always fixed or binding as the Zinc Citrate Price is obtained through a variety of data sources. The Zinc Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 546-46-3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 546-46-3, including repackagers and relabelers. The FDA regulates 546-46-3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 546-46-3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 546-46-3 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 546-46-3 supplier is an individual or a company that provides 546-46-3 active pharmaceutical ingredient (API) or 546-46-3 finished formulations upon request. The 546-46-3 suppliers may include 546-46-3 API manufacturers, exporters, distributors and traders.
click here to find a list of 546-46-3 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 546-46-3 DMF (Drug Master File) is a document detailing the whole manufacturing process of 546-46-3 active pharmaceutical ingredient (API) in detail. Different forms of 546-46-3 DMFs exist exist since differing nations have different regulations, such as 546-46-3 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 546-46-3 DMF submitted to regulatory agencies in the US is known as a USDMF. 546-46-3 USDMF includes data on 546-46-3's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 546-46-3 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 546-46-3 suppliers with USDMF on PharmaCompass.
546-46-3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 546-46-3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 546-46-3 GMP manufacturer or 546-46-3 GMP API supplier for your needs.
A 546-46-3 CoA (Certificate of Analysis) is a formal document that attests to 546-46-3's compliance with 546-46-3 specifications and serves as a tool for batch-level quality control.
546-46-3 CoA mostly includes findings from lab analyses of a specific batch. For each 546-46-3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
546-46-3 may be tested according to a variety of international standards, such as European Pharmacopoeia (546-46-3 EP), 546-46-3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (546-46-3 USP).